{{Rsnum
|rsid=576861
|Gene=ENAH
|Chromosome=1
|position=225556635
|Orientation=plus
|GMAF=0.3333
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ENAH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 6.2 | 43.4 | 50.4
| HCB | 8.0 | 31.4 | 60.6
| JPT | 11.5 | 39.8 | 48.7
| YRI | 21.8 | 48.3 | 29.9
| ASW | 14.0 | 50.9 | 35.1
| CHB | 8.0 | 31.4 | 60.6
| CHD | 11.0 | 45.9 | 43.1
| GIH | 38.6 | 44.6 | 16.8
| LWK | 12.7 | 50.9 | 36.4
| MEX | 12.1 | 48.3 | 39.7
| MKK | 7.7 | 42.9 | 49.4
| TSI | 8.8 | 45.1 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19641378
|Title=The enabled homolog gene polymorphisms are associated with susceptibility and progression of childhood IgA nephropathy
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}